Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (NCT07890571) titled 'COMPARISON OF TOPICAL VITAMIN C VS NIACINAMIDE IN TREATMENT OF MELASMA' on Oct. 16.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Pak Emirates Military Hospital

Condition: Melasma

Intervention: Drug: Ascorbic acid

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: November 1, 2026

Target Sample Size: 100

Countries of Recruitment: Pakistan

To know more, visit https://clinicaltrials.gov/study/NCT07890571

Disclaimer: Curated by HT Syndication....